Galt JR - Search Results

1

Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?

Kendi AT, Magliocca KR, Corey A, Galt JR, Switchenko J, Wadsworth JT, El-Deiry MW, Schuster DM, Saba NF, Hudgins PA. Kendi AT, et al. Among authors: galt jr. AJR Am J Roentgenol. 2016 Sep;207(3):635-40. doi: 10.2214/AJR.15.15590. Epub 2016 Jun 8. AJR Am J Roentgenol. 2016. PMID: 27276388 Free PMC article.

2

FDG imaging without PET.

Alazraki N, Galt J. Alazraki N, et al. Diagn Imaging (San Franc). 1998 Jun;20(6):74-7. Diagn Imaging (San Franc). 1998. PMID: 10180987 Review. No abstract available.

3

Choroidal melanoma with hematogenous spread to the liver: F-18 FDG PET/CT findings.

Bawa M, Sidhu G, Galt JR, Schuster DM, Halkar RK. Bawa M, et al. Among authors: galt jr. Clin Nucl Med. 2006 Jun;31(6):347-8. doi: 10.1097/01.rlu.0000220177.07728.d9. Clin Nucl Med. 2006. PMID: 16714898 No abstract available.

4

Spectrum of FDG PET/CT findings in Burkitt lymphoma.

Zeng W, Lechowicz MJ, Winton E, Cho SM, Galt JR, Halkar R. Zeng W, et al. Among authors: galt jr. Clin Nucl Med. 2009 Jun;34(6):355-8. doi: 10.1097/RLU.0b013e3181a34552. Clin Nucl Med. 2009. PMID: 19487844

5

Extramedullary acute myeloid leukemia and the use of FDG-PET/CT.

Rao S, Langston A, Galt JR, Halkar RK. Rao S, et al. Among authors: galt jr. Clin Nucl Med. 2009 Jun;34(6):365-6. doi: 10.1097/RLU.0b013e3181a3466d. Clin Nucl Med. 2009. PMID: 19487847 No abstract available.

6

Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.

Eaton BR, Kim HS, Schreibmann E, Schuster DM, Galt JR, Barron B, Kim S, Liu Y, Landry J, Fox T. Eaton BR, et al. Among authors: galt jr. J Vasc Interv Radiol. 2014 Feb;25(2):288-95. doi: 10.1016/j.jvir.2013.08.021. Epub 2013 Oct 23. J Vasc Interv Radiol. 2014. PMID: 24269792

7

A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.

Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS. Kokabi N, et al. Among authors: galt jr. J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007. J Vasc Interv Radiol. 2014. PMID: 24461133

8

Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?

Kendi AT, Magliocca K, Corey A, Nickleach DC, Galt J, Higgins K, Beitler JJ, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM. Kendi AT, et al. Clin Nucl Med. 2015 Mar;40(3):e196-200. doi: 10.1097/RLU.0000000000000691. Clin Nucl Med. 2015. PMID: 25608156 Free PMC article.

9

18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?

Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM. Kendi AT, et al. Eur J Radiol. 2015 Jun;84(6):1171-6. doi: 10.1016/j.ejrad.2015.02.030. Epub 2015 Mar 14. Eur J Radiol. 2015. PMID: 25816993 Free PMC article.

10

(90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery.

Camacho JC, Moncayo V, Kokabi N, Reavey HE, Galt JR, Yamada K, Kies DD, Williams RS, Kim HS, Schuster DM. Camacho JC, et al. Among authors: galt jr. Radiographics. 2015 Sep-Oct;35(5):1602-18. doi: 10.1148/rg.2015140314. Epub 2015 Jul 31. Radiographics. 2015. PMID: 26230755 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters